Loading…
Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)
[Display omitted] A class of inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2) was discovered. These compounds have demonstrated activity against the enzyme with IC 50 values as low as 130 nM and suppress the expression of TNFα in U937 cells. These represent the first...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters 2005-03, Vol.15 (6), p.1587-1590 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c384t-1bd7354bd97d9c992e5fe8974d19e4eb5a273a6149eee50ee72ee90aa33a42b33 |
---|---|
cites | cdi_FETCH-LOGICAL-c384t-1bd7354bd97d9c992e5fe8974d19e4eb5a273a6149eee50ee72ee90aa33a42b33 |
container_end_page | 1590 |
container_issue | 6 |
container_start_page | 1587 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 15 |
creator | Anderson, David R. Hegde, Shridhar Reinhard, Emily Gomez, Leslie Vernier, William F. Lee, Len Liu, Shuang Sambandam, Aruna Snider, Patricia A. Masih, Liaqat |
description | [Display omitted]
A class of inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2) was discovered. These compounds have demonstrated activity against the enzyme with IC
50 values as low as 130
nM and suppress the expression of TNFα in U937 cells. These represent the first small molecule inhibitors of MK-2 to be reported. |
doi_str_mv | 10.1016/j.bmcl.2005.01.067 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67481207</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X05001344</els_id><sourcerecordid>67481207</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-1bd7354bd97d9c992e5fe8974d19e4eb5a273a6149eee50ee72ee90aa33a42b33</originalsourceid><addsrcrecordid>eNp9kMFq3DAQhkVoSLZJXiCH4ktLerA7kiXLgl6WJW1CEnppITchS-NUW1veSN7Avn1sdiGn5jQD8_0_w0fIJYWCAq2-rYumt13BAEQBtIBKHpEF5RXPSw7iA1mAqiCvFX88JR9TWgNQDpyfkFMqJBc1sAWxy96Hwe5MGDa76J0PmPnw1zd-HGLKhjbrp-0JQ2bs6F_MiC7bxGFEH7J_PpiE-f8OGcuuHu5y9vWcHLemS3hxmGfkz4_r36ub_P7Xz9vV8j63Zc3HnDZOloI3TkmnrFIMRYu1ktxRhRwbYZgsTUW5QkQBiJIhKjCmLA1nTVmekS_73umP5y2mUfc-Wew6E3DYJl1JXlMGcgLZHrRxSCliqzfR9ybuNAU9q9VrPavVs1oNVE9qp9CnQ_u26dG9RQ4uJ-DzATDJmq6NJlif3rhK1ELJmfu-53By8eIx6mQ9BovOR7SjdoN_749XrSeYUQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67481207</pqid></control><display><type>article</type><title>Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</title><source>ScienceDirect Journals</source><creator>Anderson, David R. ; Hegde, Shridhar ; Reinhard, Emily ; Gomez, Leslie ; Vernier, William F. ; Lee, Len ; Liu, Shuang ; Sambandam, Aruna ; Snider, Patricia A. ; Masih, Liaqat</creator><creatorcontrib>Anderson, David R. ; Hegde, Shridhar ; Reinhard, Emily ; Gomez, Leslie ; Vernier, William F. ; Lee, Len ; Liu, Shuang ; Sambandam, Aruna ; Snider, Patricia A. ; Masih, Liaqat</creatorcontrib><description>[Display omitted]
A class of inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2) was discovered. These compounds have demonstrated activity against the enzyme with IC
50 values as low as 130
nM and suppress the expression of TNFα in U937 cells. These represent the first small molecule inhibitors of MK-2 to be reported.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2005.01.067</identifier><identifier>PMID: 15745802</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Animals ; Biological and medical sciences ; Bones, joints and connective tissue. Antiinflammatory agents ; Gene Expression ; Humans ; Kinase inhibitor ; MAP Kinase Kinase 2 - antagonists & inhibitors ; Medical sciences ; MK-2 ; Models, Chemical ; Molecular Structure ; Pharmacology. Drug treatments ; Pyridines - chemistry ; Pyridines - pharmacology ; Rats ; Structure-Activity Relationship ; TNFα ; Tumor Necrosis Factor-alpha - metabolism ; U937 Cells</subject><ispartof>Bioorganic & medicinal chemistry letters, 2005-03, Vol.15 (6), p.1587-1590</ispartof><rights>2005 Elsevier Ltd</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-1bd7354bd97d9c992e5fe8974d19e4eb5a273a6149eee50ee72ee90aa33a42b33</citedby><cites>FETCH-LOGICAL-c384t-1bd7354bd97d9c992e5fe8974d19e4eb5a273a6149eee50ee72ee90aa33a42b33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16585972$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15745802$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anderson, David R.</creatorcontrib><creatorcontrib>Hegde, Shridhar</creatorcontrib><creatorcontrib>Reinhard, Emily</creatorcontrib><creatorcontrib>Gomez, Leslie</creatorcontrib><creatorcontrib>Vernier, William F.</creatorcontrib><creatorcontrib>Lee, Len</creatorcontrib><creatorcontrib>Liu, Shuang</creatorcontrib><creatorcontrib>Sambandam, Aruna</creatorcontrib><creatorcontrib>Snider, Patricia A.</creatorcontrib><creatorcontrib>Masih, Liaqat</creatorcontrib><title>Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>[Display omitted]
A class of inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2) was discovered. These compounds have demonstrated activity against the enzyme with IC
50 values as low as 130
nM and suppress the expression of TNFα in U937 cells. These represent the first small molecule inhibitors of MK-2 to be reported.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>Gene Expression</subject><subject>Humans</subject><subject>Kinase inhibitor</subject><subject>MAP Kinase Kinase 2 - antagonists & inhibitors</subject><subject>Medical sciences</subject><subject>MK-2</subject><subject>Models, Chemical</subject><subject>Molecular Structure</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyridines - chemistry</subject><subject>Pyridines - pharmacology</subject><subject>Rats</subject><subject>Structure-Activity Relationship</subject><subject>TNFα</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>U937 Cells</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9kMFq3DAQhkVoSLZJXiCH4ktLerA7kiXLgl6WJW1CEnppITchS-NUW1veSN7Avn1sdiGn5jQD8_0_w0fIJYWCAq2-rYumt13BAEQBtIBKHpEF5RXPSw7iA1mAqiCvFX88JR9TWgNQDpyfkFMqJBc1sAWxy96Hwe5MGDa76J0PmPnw1zd-HGLKhjbrp-0JQ2bs6F_MiC7bxGFEH7J_PpiE-f8OGcuuHu5y9vWcHLemS3hxmGfkz4_r36ub_P7Xz9vV8j63Zc3HnDZOloI3TkmnrFIMRYu1ktxRhRwbYZgsTUW5QkQBiJIhKjCmLA1nTVmekS_73umP5y2mUfc-Wew6E3DYJl1JXlMGcgLZHrRxSCliqzfR9ybuNAU9q9VrPavVs1oNVE9qp9CnQ_u26dG9RQ4uJ-DzATDJmq6NJlif3rhK1ELJmfu-53By8eIx6mQ9BovOR7SjdoN_749XrSeYUQ</recordid><startdate>20050315</startdate><enddate>20050315</enddate><creator>Anderson, David R.</creator><creator>Hegde, Shridhar</creator><creator>Reinhard, Emily</creator><creator>Gomez, Leslie</creator><creator>Vernier, William F.</creator><creator>Lee, Len</creator><creator>Liu, Shuang</creator><creator>Sambandam, Aruna</creator><creator>Snider, Patricia A.</creator><creator>Masih, Liaqat</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050315</creationdate><title>Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</title><author>Anderson, David R. ; Hegde, Shridhar ; Reinhard, Emily ; Gomez, Leslie ; Vernier, William F. ; Lee, Len ; Liu, Shuang ; Sambandam, Aruna ; Snider, Patricia A. ; Masih, Liaqat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-1bd7354bd97d9c992e5fe8974d19e4eb5a273a6149eee50ee72ee90aa33a42b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>Gene Expression</topic><topic>Humans</topic><topic>Kinase inhibitor</topic><topic>MAP Kinase Kinase 2 - antagonists & inhibitors</topic><topic>Medical sciences</topic><topic>MK-2</topic><topic>Models, Chemical</topic><topic>Molecular Structure</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyridines - chemistry</topic><topic>Pyridines - pharmacology</topic><topic>Rats</topic><topic>Structure-Activity Relationship</topic><topic>TNFα</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>U937 Cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anderson, David R.</creatorcontrib><creatorcontrib>Hegde, Shridhar</creatorcontrib><creatorcontrib>Reinhard, Emily</creatorcontrib><creatorcontrib>Gomez, Leslie</creatorcontrib><creatorcontrib>Vernier, William F.</creatorcontrib><creatorcontrib>Lee, Len</creatorcontrib><creatorcontrib>Liu, Shuang</creatorcontrib><creatorcontrib>Sambandam, Aruna</creatorcontrib><creatorcontrib>Snider, Patricia A.</creatorcontrib><creatorcontrib>Masih, Liaqat</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anderson, David R.</au><au>Hegde, Shridhar</au><au>Reinhard, Emily</au><au>Gomez, Leslie</au><au>Vernier, William F.</au><au>Lee, Len</au><au>Liu, Shuang</au><au>Sambandam, Aruna</au><au>Snider, Patricia A.</au><au>Masih, Liaqat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2005-03-15</date><risdate>2005</risdate><volume>15</volume><issue>6</issue><spage>1587</spage><epage>1590</epage><pages>1587-1590</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>[Display omitted]
A class of inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2) was discovered. These compounds have demonstrated activity against the enzyme with IC
50 values as low as 130
nM and suppress the expression of TNFα in U937 cells. These represent the first small molecule inhibitors of MK-2 to be reported.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>15745802</pmid><doi>10.1016/j.bmcl.2005.01.067</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry letters, 2005-03, Vol.15 (6), p.1587-1590 |
issn | 0960-894X 1464-3405 |
language | eng |
recordid | cdi_proquest_miscellaneous_67481207 |
source | ScienceDirect Journals |
subjects | Animals Biological and medical sciences Bones, joints and connective tissue. Antiinflammatory agents Gene Expression Humans Kinase inhibitor MAP Kinase Kinase 2 - antagonists & inhibitors Medical sciences MK-2 Models, Chemical Molecular Structure Pharmacology. Drug treatments Pyridines - chemistry Pyridines - pharmacology Rats Structure-Activity Relationship TNFα Tumor Necrosis Factor-alpha - metabolism U937 Cells |
title | Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2) |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T06%3A39%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aminocyanopyridine%20inhibitors%20of%20mitogen%20activated%20protein%20kinase-activated%20protein%20kinase%202%20(MK-2)&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Anderson,%20David%20R.&rft.date=2005-03-15&rft.volume=15&rft.issue=6&rft.spage=1587&rft.epage=1590&rft.pages=1587-1590&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2005.01.067&rft_dat=%3Cproquest_cross%3E67481207%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c384t-1bd7354bd97d9c992e5fe8974d19e4eb5a273a6149eee50ee72ee90aa33a42b33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67481207&rft_id=info:pmid/15745802&rfr_iscdi=true |